Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer
Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Subjects and Methods PART included a QuinteT Recrui...
Saved in:
Published in | BJU international Vol. 122; no. 6; pp. 970 - 977 |
---|---|
Main Authors | , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
Wiley Subscription Services, Inc
01.12.2018
John Wiley and Sons Inc |
Subjects | |
Online Access | Get full text |
ISSN | 1464-4096 1464-410X 1464-410X |
DOI | 10.1111/bju.14432 |
Cover
Loading…
Abstract | Objective
To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.
Subjects and Methods
PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.
Results
Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target.
Conclusion
Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients. |
---|---|
AbstractList | To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.
PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.
Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target.
Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients. Objective To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment. Subjects and Methods PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered. Results Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target. Conclusion Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients. ObjectiveTo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.Subjects and MethodsPART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio‐recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.ResultsInitially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0–4] to 4.5 [0–12] patients/month) and the feasibility study reached its recruitment target.ConclusionAlthough clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients. To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.OBJECTIVETo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically localised prostate cancer) feasibility study and how this affected recruitment.PART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.SUBJECTS AND METHODSPART included a QuinteT Recruitment Intervention (QRI) to optimise recruitment. Phase I aimed to understand recruitment, and included: scrutinising recruitment data, interviewing the trial management group and recruiters (n = 13), and audio-recording recruitment consultations (n = 64). Data were analysed using qualitative content and thematic analysis methods. In Phase II, strategies to improve recruitment were developed and delivered.Initially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target.RESULTSInitially many recruiters found it difficult to maintain a position of equipoise and held preconceptions about which treatment was best for particular patients. They did not feel comfortable about approaching all eligible patients, and when the study was discussed, biases were conveyed through the use of terminology, poorly balanced information, and direct treatment recommendations. Individual and group feedback led to presentations to patients becoming clearer and enabled recruiters to reconsider their sense of equipoise. Although the precise impact of the QRI alone cannot be determined, recruitment increased (from a mean [range] of 1.4 [0-4] to 4.5 [0-12] patients/month) and the feasibility study reached its recruitment target.Although clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients.CONCLUSIONAlthough clinicians find it challenging to recruit patients to a trial comparing different contemporary treatments for prostate cancer, training and support can enable recruiters to become more comfortable with conveying equipoise and providing clearer information to patients. |
Author | Conte, Steffi Hindley, Richard Emara, Amr Ahmed, Hashim Rosario, Derek Hamdy, Freddie C. Brewster, Simon Dudderidge, Tim Leslie, Tom A. Donovan, Jenny L. Sooriakumaran, Prasanna Elliott, Daisy Catto, James W.F. Whybrow, Paul Emberton, Mark |
AuthorAffiliation | 5 University Hospital Southampton NHS Foundation Trust Southampton UK 9 Imperial Urology Imperial College Healthcare NHS Trust London UK 4 Department of Oncology and Metabolism University of Sheffield Sheffield UK 8 University College London Hospital NHS Foundation Trust London UK 1 Population Health Sciences Bristol Medical School University of Bristol Bristol UK 6 Hampshire Hospitals NHS Foundation Trust Basingstoke UK 2 NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust Bristol UK 3 Nuffield Department of Surgical Sciences University of Oxford Oxford UK 7 Division of Surgery and Interventional Science University College London London UK |
AuthorAffiliation_xml | – name: 8 University College London Hospital NHS Foundation Trust London UK – name: 2 NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust Bristol UK – name: 5 University Hospital Southampton NHS Foundation Trust Southampton UK – name: 3 Nuffield Department of Surgical Sciences University of Oxford Oxford UK – name: 1 Population Health Sciences Bristol Medical School University of Bristol Bristol UK – name: 7 Division of Surgery and Interventional Science University College London London UK – name: 6 Hampshire Hospitals NHS Foundation Trust Basingstoke UK – name: 4 Department of Oncology and Metabolism University of Sheffield Sheffield UK – name: 9 Imperial Urology Imperial College Healthcare NHS Trust London UK |
Author_xml | – sequence: 1 givenname: Daisy orcidid: 0000-0001-8143-9549 surname: Elliott fullname: Elliott, Daisy email: daisy.elliott@bristol.ac.uk organization: University of Bristol – sequence: 2 givenname: Freddie C. surname: Hamdy fullname: Hamdy, Freddie C. organization: University of Oxford – sequence: 3 givenname: Tom A. surname: Leslie fullname: Leslie, Tom A. organization: University of Oxford – sequence: 4 givenname: Derek surname: Rosario fullname: Rosario, Derek organization: University of Sheffield – sequence: 5 givenname: Tim surname: Dudderidge fullname: Dudderidge, Tim organization: University Hospital Southampton NHS Foundation Trust – sequence: 6 givenname: Richard surname: Hindley fullname: Hindley, Richard organization: Hampshire Hospitals NHS Foundation Trust – sequence: 7 givenname: Mark orcidid: 0000-0003-4230-0338 surname: Emberton fullname: Emberton, Mark organization: University College London – sequence: 8 givenname: Simon surname: Brewster fullname: Brewster, Simon organization: University of Oxford – sequence: 9 givenname: Prasanna surname: Sooriakumaran fullname: Sooriakumaran, Prasanna organization: University College London Hospital NHS Foundation Trust – sequence: 10 givenname: James W.F. surname: Catto fullname: Catto, James W.F. organization: University of Sheffield – sequence: 11 givenname: Amr surname: Emara fullname: Emara, Amr organization: Hampshire Hospitals NHS Foundation Trust – sequence: 12 givenname: Hashim surname: Ahmed fullname: Ahmed, Hashim organization: Imperial College Healthcare NHS Trust – sequence: 13 givenname: Paul surname: Whybrow fullname: Whybrow, Paul organization: University of Bristol – sequence: 14 givenname: Steffi surname: Conte fullname: Conte, Steffi organization: University of Oxford – sequence: 15 givenname: Jenny L. surname: Donovan fullname: Donovan, Jenny L. organization: NIHR Collaboration for Leadership in Applied Health Research and Care West at University Hospitals Bristol NHS Trust |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29888845$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kktvFDEMxyNURB9w4AugSFzgsO1kknldkErFU5V6oRK3KJNx2qwyyTbJbLWfiy-IZ7dbQSXwJZbz8z-242Ny4IMHQl6z4pShnfXL6ZQJwctn5IiJWiwEK34e7P2iqw_JcUrLosBAXb0gh2XXoonqiPy6WkPUYbT-hg7WGKsnly0kem_zLYW7ya6CTUBzoOBV74BG0HGyeQSf56iiUfkBBRIMVAefY3AO3RytcjQYulIxzy4mq2yDp-uEKYPVGFvFkLLKoHMYN9SESCdvEYOIly4gspXdY1QrryG-JM-NcglePZwn5Przpx8XXxeXV1--XZxfLvQ8i8Uw9Iw3rKuEMnXNmpo3nPUNdG3TFkqXqhCmqvoCqloo1fKmapgYas1VaUxjGD8hH3a6q6kfYdDYMdYlV9GOKm5kUFb-fePtrbwJa1lz0QrWocC7B4EY7iZIWeKYNDinPIQpybKoeNnwppvfevsEXYYpemxPloxXbdlhI0i9-bOix1L2_4nA-x2gcWQpgnlEWCHnXZG4K3K7K8iePWG1zdsvwmas-1_GvXWw-be0_Pj9epfxG2N21Vo |
CitedBy_id | crossref_primary_10_1016_j_eururo_2018_12_030 crossref_primary_10_1016_j_euf_2024_04_008 crossref_primary_10_1177_02692163231197917 crossref_primary_10_1111_bju_15669 crossref_primary_10_1136_bmjopen_2021_051698 crossref_primary_10_1186_s12874_023_02086_1 crossref_primary_10_1002_bjs5_50345 crossref_primary_10_1186_s12874_023_01881_0 crossref_primary_10_1177_1049909119851471 crossref_primary_10_3310_JNZT9406 crossref_primary_10_1016_j_eururo_2022_01_011 crossref_primary_10_1186_s13063_023_07414_w crossref_primary_10_1186_s13063_020_4227_1 crossref_primary_10_1136_bmjopen_2023_079108 crossref_primary_10_1097_SLA_0000000000005714 crossref_primary_10_1016_j_urolonc_2020_05_010 crossref_primary_10_1111_bju_14918 |
Cites_doi | 10.1186/s13063-016-1391-4 10.1186/s13063-015-0908-6 10.1186/s13063-017-2048-7 10.3310/hta20100 10.1186/s13063-015-0617-1 10.1016/j.cct.2008.03.003 10.1186/1745-6215-12-78 10.1186/s13063-017-2413-6 10.1038/nrclinonc.2014.44 10.1371/journal.pmed.1002147 10.1016/j.jclinepi.2014.03.010 10.1056/NEJMoa1606220 10.1016/j.eururo.2017.04.036 10.1016/j.jclinepi.2008.02.010 10.1038/bjc.2014.313 10.1016/j.eururo.2016.08.044 10.3310/hta19490 |
ContentType | Journal Article |
Copyright | 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International. BJUI © 2018 BJU International |
Copyright_xml | – notice: 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International – notice: 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International. – notice: BJUI © 2018 BJU International |
DBID | 24P AAYXX CITATION CGR CUY CVF ECM EIF NPM 7QP 7X8 5PM |
DOI | 10.1111/bju.14432 |
DatabaseName | Wiley Online Library Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Calcium & Calcified Tissue Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE Calcium & Calcified Tissue Abstracts MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: 24P name: Wiley Online Library Open Access url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Elliott et al |
EISSN | 1464-410X |
EndPage | 977 |
ExternalDocumentID | PMC6348419 29888845 10_1111_bju_14432 BJU14432 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Wellcome Trust – fundername: Medical Research Council (MRC) – fundername: Trod Medical – fundername: Health Technology Assessment (HTA) programme funderid: 12/35/54 – fundername: Sophiris Inc. – fundername: Collaboration for Leadership in Applied Health Research and Care (CLAHRC) – fundername: Prostate Cancer UK – fundername: National Institute for Health Research – fundername: Sonacare Inc. – fundername: UCLH/UCL NIHR Biomedical Research Centre – fundername: Medical Research Council grantid: MR/K025643/1 – fundername: Department of Health grantid: HTA/12/35/54 – fundername: Health Technology Assessment (HTA) programme grantid: 12/35/54 |
GroupedDBID | --- .3N .55 .GA .Y3 05W 0R~ 10A 1OC 23N 24P 2WC 31~ 33P 36B 3O- 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6P2 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AAHQN AAIPD AAMNL AANLZ AAONW AASGY AAXRX AAYCA AAZKR ABCQN ABCUV ABDBF ABEML ABJNI ABLJU ABOCM ABPVW ABQWH ABXGK ACAHQ ACCFJ ACCZN ACFBH ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACUHS ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFFNX AFFPM AFGKR AFPWT AFWVQ AFZJQ AHBTC AHMBA AIACR AITYG AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN ALVPJ AMBMR AMYDB ATUGU AZBYB AZVAB BAFTC BAWUL BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG COF CS3 D-6 D-7 D-E D-F DCZOG DIK DPXWK DR2 DRFUL DRMAN DRSTM DU5 E3Z EAD EAP EBC EBD EBS EJD EMB EMK EMOBN ESX EX3 F00 F01 F04 F5P FUBAC G-S G.N GODZA H.X HF~ HGLYW HZI HZ~ IHE IX1 J0M J5H K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OK1 OVD P2P P2W P2X P2Z P4B P4D PQQKQ Q.N Q11 QB0 R.K RJQFR ROL RX1 SUPJJ SV3 TEORI TUS UB1 V9Y W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WRC WVDHM WXI WXSBR X7M XG1 YFH ZGI ZXP ~IA ~WT AAYXX AEYWJ AGHNM AGYGG CITATION AAMMB AEFGJ AGXDD AIDQK AIDYY CGR CUY CVF ECM EIF NPM 1OB 7QP 7X8 5PM |
ID | FETCH-LOGICAL-c4432-ddb1371954af661763731b7e98780ac2a04f55b0e564aa8375714d6c3a2ff7f13 |
IEDL.DBID | DR2 |
ISSN | 1464-4096 1464-410X |
IngestDate | Thu Aug 21 18:31:02 EDT 2025 Tue Aug 05 11:27:07 EDT 2025 Wed Aug 13 07:26:00 EDT 2025 Mon Jul 21 06:03:16 EDT 2025 Thu Apr 24 23:01:28 EDT 2025 Tue Jul 01 03:50:16 EDT 2025 Wed Jan 22 17:09:11 EST 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | feasibility equipoise qualitative recruitment PCSM ProstateCancer randomised controlled trial |
Language | English |
License | Attribution 2018 The Authors BJU International published by John Wiley & Sons Ltd on behalf of BJU International. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4432-ddb1371954af661763731b7e98780ac2a04f55b0e564aa8375714d6c3a2ff7f13 |
Notes | Correction added on 18 January 2019 after first online publication: the legal statement and copyright details have been updated in this version ObjectType-Article-2 SourceType-Scholarly Journals-1 content type line 14 ObjectType-Feature-3 ObjectType-Evidence Based Healthcare-1 ObjectType-Article-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-8143-9549 0000-0003-4230-0338 |
OpenAccessLink | https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.14432 |
PMID | 29888845 |
PQID | 2135829195 |
PQPubID | 1026371 |
PageCount | 8 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6348419 proquest_miscellaneous_2053273791 proquest_journals_2135829195 pubmed_primary_29888845 crossref_primary_10_1111_bju_14432 crossref_citationtrail_10_1111_bju_14432 wiley_primary_10_1111_bju_14432_BJU14432 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | December 2018 |
PublicationDateYYYYMMDD | 2018-12-01 |
PublicationDate_xml | – month: 12 year: 2018 text: December 2018 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Edgecliff – name: Hoboken |
PublicationTitle | BJU international |
PublicationTitleAlternate | BJU Int |
PublicationYear | 2018 |
Publisher | Wiley Subscription Services, Inc John Wiley and Sons Inc |
Publisher_xml | – name: Wiley Subscription Services, Inc – name: John Wiley and Sons Inc |
References | 2017; 72 2018; 19 2015; 16 2009; 62 2017; 71 2015; 19 2008; 29 2016; 20 2016; 375 2017 2017; 18 2011; 12 2016; 17 2014; 111 2014; 67 2014; 11 2016; 13 1967 e_1_2_8_17_1 e_1_2_8_18_1 e_1_2_8_19_1 Hamdy FC (e_1_2_8_8_1) 2017 e_1_2_8_13_1 e_1_2_8_14_1 e_1_2_8_15_1 e_1_2_8_16_1 e_1_2_8_3_1 e_1_2_8_2_1 e_1_2_8_5_1 e_1_2_8_4_1 e_1_2_8_7_1 e_1_2_8_6_1 e_1_2_8_20_1 e_1_2_8_10_1 e_1_2_8_11_1 e_1_2_8_12_1 Glaser BG (e_1_2_8_9_1) 1967 |
References_xml | – volume: 72 start-page: 789 year: 2017 end-page: 98 article-title: Understanding and improving recruitment to randomised controlled trials: qualitative research approaches publication-title: Eur Urol – volume: 29 start-page: 663 year: 2008 end-page: 70 article-title: Qualitative research to improve RCT recruitment: issues arising in establishing research collaborations publication-title: Contemp Clin Trials – volume: 71 start-page: 17 year: 2017 end-page: 34 article-title: New and established technology in focal ablation of the prostate: a systematic review publication-title: Eur Urol – volume: 20 start-page: 1 year: 2016 end-page: 201 article-title: OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer publication-title: Health Technol Assess – volume: 19 start-page: 50 year: 2018 article-title: Development of a framework to improve the process of recruitment to randomised controlled trials (RCTs): the SEAR (Screened, Eligible, Approached, Randomised) framework publication-title: Trials – year: 2017 article-title: A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer publication-title: Health Technol Assess – year: 1967 – volume: 18 start-page: 327 year: 2017 article-title: Informed consent in randomised controlled trials: development and preliminary evaluation of a measure of Participatory and Informed Consent (PIC) publication-title: Trials – volume: 19 start-page: 1 year: 2015 end-page: 490 article-title: Ablative therapy for people with localised prostate cancer: a systematic review and economic evaluation publication-title: Health Technol Assess – volume: 12 start-page: 78 year: 2011 article-title: Key issues in recruitment to randomised controlled trials with very different interventions: a qualitative investigation of recruitment to the SPARE trial (CRUK/07/011) publication-title: Trials – volume: 16 start-page: 432 year: 2015 article-title: A systematic review of training programmes for recruiters to randomised controlled trials publication-title: Trials – volume: 16 start-page: 88 year: 2015 article-title: A simple technique to identify key recruitment issues in randomised controlled trials: Q‐QAT‐quanti‐qualitative appointment timing publication-title: Trials – volume: 111 start-page: 234 year: 2014 end-page: 40 article-title: Feasibility RCT of definitive chemoradiotherapy or chemotherapy and surgery for oesophageal squamous cell cancer publication-title: Br J Cancer – volume: 13 start-page: e1002147 year: 2016 article-title: Conveying equipoise during recruitment for clinical trials: qualitative synthesis of clinicians’ practices across six randomised controlled trials publication-title: PLoS Med – volume: 62 start-page: 29 year: 2009 end-page: 36 article-title: Development of a complex intervention improved randomisation and informed consent in a randomized controlled trial publication-title: J Clin Epidemiol – volume: 67 start-page: 912 year: 2014 end-page: 20 article-title: The intellectual challenges and emotional consequences of equipoise contributed to the fragility of recruitment in six randomised controlled trials publication-title: J Clin Epidemiol – volume: 375 start-page: 1415 year: 2016 end-page: 24 article-title: 10‐Year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer publication-title: N Engl J Med – volume: 11 start-page: 482 year: 2014 end-page: 91 article-title: Can we deliver randomized trials of focal therapy in prostate cancer? publication-title: Nat Rev Clin Oncol – volume: 17 start-page: 283 year: 2016 article-title: Optimising recruitment and informed consent in randomised controlled trials: the development and implementation of the Quintet Recruitment Intervention (QRI) publication-title: Trials – ident: e_1_2_8_6_1 doi: 10.1186/s13063-016-1391-4 – ident: e_1_2_8_13_1 doi: 10.1186/s13063-015-0908-6 – ident: e_1_2_8_17_1 doi: 10.1186/s13063-017-2048-7 – ident: e_1_2_8_15_1 doi: 10.3310/hta20100 – ident: e_1_2_8_16_1 doi: 10.1186/s13063-015-0617-1 – ident: e_1_2_8_19_1 doi: 10.1016/j.cct.2008.03.003 – volume-title: The Discovery of Grounded Theory: Strategies for Qualitative Research year: 1967 ident: e_1_2_8_9_1 – ident: e_1_2_8_20_1 doi: 10.1186/1745-6215-12-78 – ident: e_1_2_8_11_1 doi: 10.1186/s13063-017-2413-6 – ident: e_1_2_8_5_1 doi: 10.1038/nrclinonc.2014.44 – ident: e_1_2_8_10_1 doi: 10.1371/journal.pmed.1002147 – ident: e_1_2_8_12_1 doi: 10.1016/j.jclinepi.2014.03.010 – year: 2017 ident: e_1_2_8_8_1 article-title: A randomised controlled trial of Partial prostate Ablation versus Radical prosTatectomy (PART) in intermediate risk, unilateral clinically localised prostate cancer publication-title: Health Technol Assess – ident: e_1_2_8_2_1 doi: 10.1056/NEJMoa1606220 – ident: e_1_2_8_7_1 doi: 10.1016/j.eururo.2017.04.036 – ident: e_1_2_8_14_1 doi: 10.1016/j.jclinepi.2008.02.010 – ident: e_1_2_8_18_1 doi: 10.1038/bjc.2014.313 – ident: e_1_2_8_3_1 doi: 10.1016/j.eururo.2016.08.044 – ident: e_1_2_8_4_1 doi: 10.3310/hta19490 |
SSID | ssj0014665 |
Score | 2.3681207 |
Snippet | Objective
To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral... To describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate-risk unilateral clinically... ObjectiveTo describe how clinicians conceptualised equipoise in the PART (Partial prostate Ablation vs Radical prosTatectomy in intermediate‐risk unilateral... |
SourceID | pubmedcentral proquest pubmed crossref wiley |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 970 |
SubjectTerms | Ablation Attitude of Health Personnel Cancer surgery Data processing equipoise feasibility Feasibility Studies Humans Male Patient Selection - ethics Patients PCSM Prostate cancer ProstateCancer Prostatectomy Prostatectomy - statistics & numerical data Prostatic Neoplasms - pathology Prostatic Neoplasms - therapy qualitative Qualitative Research Radiofrequency Ablation - statistics & numerical data randomised controlled trial Randomized Controlled Trials as Topic - methods Recruitment Research Subjects - statistics & numerical data Terminology Therapeutic Equipoise Trial Urological surgery |
Title | Overcoming difficulties with equipoise to enable recruitment to a randomised controlled trial of partial ablation vs radical prostatectomy for unilateral localised prostate cancer |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fbju.14432 https://www.ncbi.nlm.nih.gov/pubmed/29888845 https://www.proquest.com/docview/2135829195 https://www.proquest.com/docview/2053273791 https://pubmed.ncbi.nlm.nih.gov/PMC6348419 |
Volume | 122 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VHhAX3tCFUg2IA5dUm8SJHXECRFVVKiDESj0gRU5si9CSLJsNEv1b_YPMOA91KUiIvay1GTv2ejwz9oy_AXhujBE6k2HA6VUDYZwOFEO4OqkKpUriAI_EdPwuPVyIo5PkZAtejndhenyI6cCNV4aX17zAddFeWuTF1449kzHLX47VYoPo4wQdRQLAp5Gkb-oC2ekDqhBH8Uw1N3XRFQPzapzkZfvVK6CDW_B57Hofd3K6362L_fL8N1TH_xzbbbg5GKb4quekO7Bl67tw_Xhwvd-Di_fE9NQOqTrkrCoes4O22cgnuWi_d9WyqVqL6watv4-FJEtXXeWj2PlXjaQWDTXQWoNDhPwZFX3eEGwcLpmLqUiVPbvgj5aqeD8SLvlyimaHR_PtJ5KhjV1dERmfqKHXx77ZkQxLZubVfVgcvP305jAYMj4EJY82MKYIY8kgdNqR4UCyT8ZhIW2mpJrrMtJz4ZKkmNskFVrT3jqRoTBpGevIOenC-AFs101tdwCdEUlG9qFJtGKUQSV1qpJUZqXRVkV2Bi_Guc_LAQ6ds3Kc5eO2iCYh95Mwg2cT6bLHAPkT0e7IQPkgBto8CvkickYDmsHT6TH90eyV0bVtOqLh3Bwyllk4g4c9v01viTJFH0G15QYnTgQMDr75pK6-eJDwNBZKhBkN0zPa3zuevz5a-MKjfyd9DDfIcFR9WM8ubK9XnX1Cxtm62INrkfiw59fiL_t2O8A |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3db9MwED9NmwS8jG9WNuBAPPCSqUmc2JF4AcRUxjoktEp7QZETOyIwktI2k8a_xT_InfOhlYGE6Eut5uzY9fnu7Dv_DuC5MUboRPoep1f1hCm0pxjCtZAqUyonDnBITNPjeDITh6fR6Qa87O_CtPgQw4Ebrwwnr3mB84H0pVWefWnYNRmSAN7ijN5uQ_VxAI8iEeASSdI3dYIs9Q5XiON4hqrr2uiKiXk1UvKyBetU0MFN-NR3vo08-brfrLL9_MdvuI7_O7pbsN3ZpviqZabbsGGrO3Bt2nnf78LPD8T31BBpO-TEKg62g3bayIe5aL835bwulxZXNVp3JQtJnC6a0gWy868aSTMaamBpDXZB8mdUdKlDsC5wzoxMRarsOAbPl1TFuZJwzvdTNPs86m8XSLY2NlVJZHyohk4lu2Z7MsyZnxf3YHbw9uTNxOuSPng5j9YzJvNDyTh0uiDbgcSfDP1M2kRJNdZ5oMeiiKJsbKNYaE3b60j6wsR5qIOikIUf3ofNqq7sDmBhRJSQiWgirRhoUEkdqyiWSW60VYEdwYt-8tO8Q0TnxBxnab8zoklI3SSM4NlAOm9hQP5EtNdzUNpJgmUa-HwXOaEBjeDp8Jj-aHbM6MrWDdFweg4ZysQfwYOW4Ya3BImij6Daco0VBwLGB19_UpWfHU54HAol_ISG6Tjt7x1PXx_OXOHhv5M-geuTk-lRevTu-P0u3CA7UrVRPnuwuVo09hHZaqvssVuSvwALCT8E |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VRaq48CiPbilgEAcuqTaJEzviRCmrUmhBiJV6QIqc2FZT2iTsbpDav8Uf7IzzULcFCbGXtTZjx15_Ho_t8TcAr7TWXCXC9yi8qse1VZ4kClcrZCZljghwTEwHh_HelO8fRUcr8Ka_C9PyQwwbbjQynL6mAV5re2WQZycNnUyGqH9v8XgsCdK7XwfuKNQALo4kfmMd0FDvaIXIjWfIujwZ3bAwbzpKXjVg3Qw0uQvf-7q3jic_tptFtp1fXKN1_M_G3YM7nWXK3rZQug8rplyHtYPu7P0B_P6MqMdycK5jFFbFkXbgOpvRVi4zP5uiroq5YYuKGXchi6EynTWFc2OnXxXDeVFjAXOjWecif4pJFziEVZbVBGNMYmaHF_ZrjlncQRKr6XaKohOP6uycoaXNmrJAMdpSY25CdsX2YiwnNM8ewnTy_tu7Pa8L-eDl1FpP68wPBbHQKYuWAyo_EfqZMIkUcqzyQI25jaJsbKKYK4WL60j4XMd5qAJrhfXDR7BaVqXZAGY1jxI0EHWkJNEMSqFiGcUiybUyMjAjeN33fZp3fOgUluM07ddF2Amp64QRvBxE65YE5E9CWz2A0k4PzNPAp5vICTZoBC-Gx_hH07GMKk3VoAwF5xChSPwRPG7xNrwlSCR-OOYWS0gcBIgdfPlJWRw7lvA45JL7CTbTAe3vFU939qcusfnvos9h7cvuJP304fDjE7iNRqRsXXy2YHUxa8xTNNQW2TM3IC8BUEo9vA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Overcoming+difficulties+with+equipoise+to+enable+recruitment+to+a+randomised+controlled+trial+of+partial+ablation+vs+radical+prostatectomy+for+unilateral+localised+prostate+cancer&rft.jtitle=BJU+international&rft.au=Elliott%2C+Daisy&rft.au=Hamdy%2C+Freddie+C&rft.au=Leslie%2C+Tom+A&rft.au=Rosario%2C+Derek&rft.date=2018-12-01&rft.issn=1464-410X&rft.eissn=1464-410X&rft.volume=122&rft.issue=6&rft.spage=970&rft_id=info:doi/10.1111%2Fbju.14432&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1464-4096&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1464-4096&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1464-4096&client=summon |